Cargando…
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review
Background: Although common drugs for treating type 2 diabetes (T2D) are widely used, their therapeutic effects vary greatly. The interaction between the gut microbiome and glucose-lowering drugs is one of the main contributors to the variability in T2D progression and response to therapy. On the on...
Autores principales: | Li, Ruolin, Shokri, Fereshteh, Rincon, Alejandro Lopez, Rivadeneira, Fernando, Medina-Gomez, Carolina, Ahmadizar, Fariba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454120/ https://www.ncbi.nlm.nih.gov/pubmed/37628624 http://dx.doi.org/10.3390/genes14081572 |
Ejemplares similares
-
Type 2 Diabetes Clusters Indicate Diabetes Duration Key in Fracture Risk
por: Ghatan, Sam, et al.
Publicado: (2021) -
Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review
por: Shahisavandi, Mina, et al.
Publicado: (2023) -
Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines
por: Mohammadi Jouabadi, Soroush, et al.
Publicado: (2022) -
Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020) -
Immunomodulatory Role of Vitamin D on Gut Microbiome in Children
por: Tabassum, Anika, et al.
Publicado: (2023)